Cadila, 2013 film

With the surge in demand for hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, the pharmaceutical industry has produced 20 crore HCQ tablets this month, said Pankaj Patel, CEO of Zydus Cadila in Ahmedabad, on Saturday."The pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ). 20 crore tablets of HCQ have been produced by the industry this month," Patel told .To meet the domestic and foreign demand for hydroxychloroquine, Cadila will produce 30 tonnes of active pharmaceutical ingredient (API) equivalent to 15 crore tablets next month."We have sufficient stock available, not only for the domestic market, but we would be able to supply to the world if the need arises. My company will produce 30 tonnes of API equivalent to 15 crore tablets next month," he said.Several countries have requested India for the supply of the said drug even as the globally confirmed cases of the virus, which originated in China's Wuhan last year, has surpassed 1.5 million.India has cleared the first list of 13 countries for hydroxychloroquine which includes the USA, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Sri Lanka, Afghstan, Maldives, and Bangladesh.They said USA had asked for 48 lakh tablets of HCQ and India has sanctioned 35.82 lakh tablets, sources said.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Narendra Modi

Lok Sabha Election 2024

Heatwave In India

Mumbai Mega Block

Maharashtra Lok Sabha Election

T20 World Cup 2024

CadilaFOLLOW

Cadila, Latest News

Health :Schools can reopen without vaccinating children, says V.K. Paul

New Delhi, Sep 9 Children need not be vaccinated for schools to reopen, NITI Aayog's Member, Health, Dr ... ...

National :Pharmaceutical industry produces 20 cr hydroxychloroquine tablets this month: Zydus Cadila CEO

With the surge in demand for hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, the pharmaceutical industry has produced 20 crore HCQ tablets this month, said Pankaj Patel, CEO of Zydus Cadila in Ahmedabad, on Sat ...